INVITRO CHARACTERIZATION OF COMMERCIAL FACTOR-VIII CONCENTRATES - LONG-TERM FOLLOW-UP

被引:5
作者
MIYASHITA, C [1 ]
HELLSTERN, P [1 ]
KOHLER, M [1 ]
VONBLOHN, G [1 ]
WENZEL, E [1 ]
机构
[1] UNIV SAARLANDES KLINIKEN,KLIN HAMOSTASEOL & TRANSFUS MED ABT,FACHBEREICH 43,D-6650 HOMBURG,FED REP GER
来源
BLUT | 1984年 / 49卷 / 01期
关键词
D O I
10.1007/BF00320384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:53 / 59
页数:7
相关论文
共 13 条
[1]  
AUSTEN DEG, 1981, LANCET, V2, P1167
[2]  
BARROWCLIFFE TW, 1981, LANCET, V2, P1342
[3]   STANDARDIZATION OF FACTOR-VIII .1. CALIBRATION OF BRITISH STANDARDS FOR FACTOR-VIII CLOTTING ACTIVITY [J].
BARROWCLIFFE, TW ;
KIRKWOOD, TBL .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 46 (03) :471-481
[4]  
BEESER H, 1982, 11 HAM S HAMB, P35
[5]  
KRONIGER A, 1982, MED WELT, V33, P1027
[6]  
LANG H, 1982, 11 HAM S HAMB, P53
[8]   HEMOLYSIS CAUSED BY FACTOR-VIII CONCENTRATES [J].
ORRINGER, EP ;
KOURY, MJ ;
BLATT, PM ;
ROBERTS, HR .
ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (09) :1018-1020
[9]   HEMOLYTIC ANEMIA DUE TO ANTI-A IN CONCENTRATED ANTIHEMOPHILIC FACTOR PREPARATIONS [J].
ROSATI, LA ;
BARNES, B ;
OBERMAN, HA ;
PENNER, JA .
TRANSFUSION, 1970, 10 (03) :139-&
[10]  
SCHIMPF K, 1981, 12 HAM S HAMB, P1